Surgical treatment of non-functioning pancreatic islet cell tumors

被引:45
作者
Kouvaraki, MA
Solorzano, CC
Shapiro, SE
Yao, JC
Perrier, ND
Lee, JE
Evans, DB
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Unit 444, Houston, TX 77230 USA
[2] Univ Miami, Jackson Mem Med Ctr, Div Surg Oncol, Dept Surg, Miami, FL USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
关键词
pancreatic endocrine tumor; non-functioning; MEN1; VHL; therapy;
D O I
10.1002/jso.20178
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pancreatic endocrine tumors (PETs) are rare neoplasms oriainating from the amine precursor uptake and decarboxylation (APUD) stein cells. Although the majority of PETs are sporadic, they frequently occur in familial syndromes. PETs may cause a variety of functional syndromes or symptoms of local progression if they are nonfunctional. General neuroendocrine tumor markers are highly sensitive in the diaonostic assessment of a PET. Imaging studies for tumor localization and staging include computer tomography (CT) scan, magnetic resonance imaging (MRI), In-111-octreotide scan, MIBG, and endoscopic ultrasonography (EUS). Treatment of PETs often requires a multi-modality approach; however, surgical resection remains the only curative therapy for localized (non-metastatic) disease. Treatment of metastatic disease includes biologic agents, cytotoxic chemotherapy, and liver-directed therapies. (C) 2005 Wiley-Liss, Inc.
引用
收藏
页码:170 / 185
页数:16
相关论文
共 230 条
  • [1] ACKERMAN NB, 1972, SURGERY, V71, P636
  • [2] SECRETION OF PANCREATIC-POLYPEPTIDE IN PATIENTS WITH PANCREATIC ENDOCRINE TUMORS
    ADRIAN, TE
    UTTENTHAL, LO
    WILLIAMS, SJ
    BLOOM, SR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (05) : 287 - 391
  • [3] Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription
    Agarwal, SK
    Guru, SC
    Heppner, C
    Erdos, MR
    Collins, RM
    Park, SY
    Saggar, S
    Chandrasekharappa, SC
    Collins, FS
    Spiegel, AM
    Marx, SJ
    Burns, AL
    [J]. CELL, 1999, 96 (01) : 143 - 152
  • [4] ISLET CELL TUMORS METASTATIC TO THE LIVER - EFFECTIVE PALLIATION BY SEQUENTIAL HEPATIC-ARTERY EMBOLIZATION
    AJANI, JA
    CARRASCO, CH
    CHARNSANGAVEJ, C
    SAMAAN, NA
    LEVIN, B
    WALLACE, S
    [J]. ANNALS OF INTERNAL MEDICINE, 1988, 108 (03) : 340 - 344
  • [5] ALESSIANI M, 1995, J AM COLL SURGEONS, V180, P1
  • [6] Andrew A, 1998, J PATHOL, V186, P117, DOI 10.1002/(SICI)1096-9896(1998100)186:2<117::AID-PATH152>3.0.CO
  • [7] 2-J
  • [8] SOMATOSTATIN ANALOG SANDOSTATIN AND INHIBITION OF TUMOR-GROWTH IN PATIENTS WITH METASTATIC ENDOCRINE GASTROENTEROPANCREATIC TUMORS
    ARNOLD, R
    NEUHAUS, C
    BENNING, R
    SCHWERK, WB
    TRAUTMANN, ME
    JOSEPH, K
    BRUNS, C
    [J]. WORLD JOURNAL OF SURGERY, 1993, 17 (04) : 511 - 519
  • [9] MANAGEMENT OF GASTROENTEROPANCREATIC ENDOCRINE TUMORS - THE PLACE OF SOMATOSTATIN ANALOGS
    ARNOLD, R
    FRANK, M
    KAJDAN, U
    [J]. DIGESTION, 1994, 55 : 107 - 113
  • [10] Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours
    Arnold, R
    Trautmann, ME
    Creutzfeldt, W
    Benning, R
    Benning, M
    Neuhaus, C
    Jurgensen, R
    Stein, K
    Schafer, H
    Bruns, C
    Dennler, HJ
    [J]. GUT, 1996, 38 (03) : 430 - 438